Infectious Complications in Cancer Patients

1. Front Matter

   Pages i-x

   PDF

2. Host Impairments in Patients with Neoplastic Diseases

   • J. Peter Donnelly, Nicole M. A. Blijlevens, Walter J. F. M. van der Velden

   Pages 1-41

3. Epidemiology of Infections in Cancer Patients

   • Teresa R. Zembower

   Pages 43-89

4. Bacterial Pathogens

   • John W. Wilson

   Pages 91-128

5. Fungal Infections in Cancer Patients

   • Michael Angarone

   Pages 129-155

6. Advances in the Management of Viral Infections

   • Jack W. Hsu, John R. Wingard

   Pages 157-180

7. Neutropenic Fever and Sepsis: Evaluation and Management

   • Kenneth V. I. Rolston

   Pages 181-202

8. Respiratory Infections

   • Evan J. Anderson

   Pages 203-236

9. Enteric Infections

   • Michael Wang, Stuart Johnson

   Pages 237-251

10. Central Nervous System Infections in Cancer Patients and Hematopoietic Stem Cell Transplant Recipients

    • Michael J. Hoffman, Valentina Stosor

    Pages 253-298

11. Dermatologic Infections in Cancer Patients

    • Mona Gandhi, Joaquin C. Brieva, Mario E. Lacouture

    Pages 299-317

12. Infections in Patients with Leukemia and Lymphoma

    • Vicki A. Morrison

    Pages 319-349

13. Infectious Complications of Stem Cell Transplantation

    • Charulata Ramaprasad, Kenneth J. Pursell

    Pages 351-370

14. Infections Associated with Solid Malignancies

    • Sarah H. Sutton

    Pages 371-411

15. Antimicrobial Agents, Drug Adverse Reactions and Interactions, and Cancer

    • Ximena Millan, Victoria Muggia, Belinda Ostrowsky

    Pages 413-462

16. Infection Control and Prevention Considerations

    • Titus L. Daniels, Thomas R. Talbot

    Pages 463-483

17. Prevention of Infection in Cancer Patients

    • Diana Pomakova, Brahm H. Segal

    Pages 485-511

While advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neo plastic disease. In this patient population, infection risk results from a complex interplay between the host’s underlying immunodeficiencies, local tumor effects and treatment-induced immunosuppression. New chemotherapeutic approaches and antimicrobial prophylaxis and treatment practices continue to shape the spectrum of infections in these patients. Clinicians who treat infections in cancer patients are continually challenged by the emergence of new pathogens and by the increasing antimicrobial resistance of established ones. The aim of this book is to emphasize unique aspects of management of infectious diseases in the cancer patient. With the increasing complexity of this patient population, optimal management requires a multidisciplinary approach and this fact is fully reflected in the contributions, all from recognized authorities in the field. Ultimately, it is hoped that this volume will assist specialists in infectious diseases and haematology/oncology in the diagnosis, management and prevention of infection and optimization of the overall care of patients with malignancies.

• Antimicrobial Resistence
• Hematology
• Neoplastic Disease
• Oncology
• Pathogens
• infectious diseases

• Div. Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, USA

  Valentina Stosor

• Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, USA

  Teresa R. Zembower

Policies and ethics